Institut Cochin, INSERM U1016, CNRS UMR 8104, Université de Paris, Paris, France.
Epigenetics and Cell Fate Center, CNRS UMR 7216, Université de Paris, Paris, France.
J Biol Chem. 2021 Jul;297(1):100839. doi: 10.1016/j.jbc.2021.100839. Epub 2021 May 27.
Glucose-mediated signaling regulates the expression of a limited number of genes in human pancreatic β-cells at the transcriptional level. However, it is unclear whether glucose plays a role in posttranscriptional RNA processing or translational control of gene expression. Here, we asked whether glucose affects posttranscriptional steps and regulates protein synthesis in human β-cell lines. We first showed the involvement of the mTOR pathway in glucose-related signaling. We also used the surface sensing of translation technique, based on puromycin incorporation into newly translated proteins, to demonstrate that glucose treatment increased protein translation. Among the list of glucose-induced proteins, we identified the proconvertase PCSK1, an enzyme involved in the proteolytic conversion of proinsulin to insulin, whose translation was induced within minutes following glucose treatment. We finally performed global proteomic analysis by mass spectrometry to characterize newly translated proteins upon glucose treatment. We found enrichment in proteins involved in translation, glycolysis, TCA metabolism, and insulin secretion. Taken together, our study demonstrates that, although glucose minorly affects gene transcription in human β-cells, it plays a major role at the translational level.
葡萄糖介导的信号转导在转录水平上调节人胰腺β细胞中有限数量的基因表达。然而,目前尚不清楚葡萄糖是否在基因表达的转录后 RNA 加工或翻译调控中发挥作用。在这里,我们研究了葡萄糖是否影响人β细胞系中的转录后步骤和调节蛋白质合成。我们首先证明了 mTOR 途径参与葡萄糖相关信号转导。我们还使用基于新翻译蛋白掺入的翻译表面感应技术,证明了葡萄糖处理可增加蛋白质翻译。在葡萄糖诱导的蛋白质列表中,我们鉴定了前转化酶 PCSK1,它是一种参与将胰岛素原转化为胰岛素的酶,其翻译在葡萄糖处理后几分钟内被诱导。最后,我们通过质谱进行了全局蛋白质组学分析,以描述葡萄糖处理时新翻译的蛋白质。我们发现与翻译、糖酵解、三羧酸 (TCA) 代谢和胰岛素分泌相关的蛋白质富集。总之,我们的研究表明,尽管葡萄糖在人β细胞中对基因转录的影响较小,但它在翻译水平上起着主要作用。
Front Endocrinol (Lausanne). 2022
J Endocrinol. 2010-11-17
Exp Mol Med. 2010-6-30
Mol Cell Endocrinol. 2020-12-1
Mol Metab. 2025-5-30
J Clin Invest. 2024-6-17
J Clin Invest. 2023-11-30
Front Endocrinol (Lausanne). 2022